Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
about
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients.Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence.Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice.The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration.HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study.Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life.International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UKVirologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis
P2860
Q36311127-81A969D3-24AA-4D91-83AF-F7A6F730C241Q39453985-F17CACCD-9518-4819-A599-36EA4C9F7FD2Q40150911-8F2BE2B9-051A-4FF7-BF0D-FCA341AEDB02Q40257857-83EBE8A7-F4EB-4AE2-9715-A63BC6999D61Q47593950-0A4C87E7-2BDE-4D8B-8A20-85E01105CCB9Q47800071-EEFDE8B3-20AA-4E89-845B-443D21D470ABQ47801252-8BF8A33C-D430-4527-ABE3-3251C77432E7Q56762706-B1A202CE-2208-43AA-88E4-13B01AEFA2A7Q57131201-FBF4C19B-B351-4980-AC2C-C03DE5F98C39
P2860
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
@en
type
label
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
@en
prefLabel
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
@en
P2093
P2860
P356
P1476
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
@en
P2093
A-G Marcelin
E Valdenassi
G Peytavin
L Schneider
M Kirstetter
M-A Valantin
P2860
P304
P356
10.1093/JAC/DKW186
P407
P577
2016-06-10T00:00:00Z